Episodic Future Thinking for HIV Prevention
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new therapy called Episodic Future Thinking (EFT) to help individuals reduce drug use and risky sexual behaviors while adhering to their HIV prevention medication, PrEP. Participants will be divided into two groups: one will receive standard care with counseling, and the other will receive standard care plus the EFT program, which involves setting future goals with the help of an app and counseling sessions. This trial is suitable for gay or bisexual men who are HIV-negative, have recently used meth, are on PrEP but struggle with regular adherence, and have engaged in condomless sex or had a recent STI. As an unphased trial, this study provides a unique opportunity to explore innovative methods to improve PrEP adherence and reduce risky behaviors.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, you must be currently taking HIV PrEP medication to participate.
What prior data suggests that this behavioral therapy is safe?
Research has shown that Episodic Future Thinking (EFT) is a new method being tested to help people make better choices, such as using fewer drugs and avoiding risky sexual behaviors. EFT is a non-pharmacological therapy, making it generally easy for individuals to manage. Studies have not reported any serious side effects directly caused by EFT. This approach uses counseling and a mobile app to help people focus on their future goals, distinguishing it from treatments that might have physical side effects. So far, EFT appears to be a safe option for those seeking to improve their health-related decisions.12345
Why are researchers excited about this trial?
Researchers are excited about Episodic Future Thinking (EFT) for HIV prevention because it tackles decision-making in a novel way. Unlike current treatments that focus on medication and behavioral counseling, EFT leverages a behavioral economic approach. It uses an app to help individuals imagine future scenarios, which can reduce impulsive decisions and improve long-term planning. By combining in-person counseling with mobile health technology, EFT offers a new, accessible method to encourage safer behaviors and better choices, potentially enhancing the effectiveness of existing prevention strategies.
What evidence suggests that Episodic Future Thinking is effective for reducing drug use and risky sexual behaviors in HIV prevention?
Research has shown that Episodic Future Thinking (EFT), which participants in this trial may receive through an app platform, can help people make safer choices and improve decision-making. Several studies have found EFT effective in reducing drug use and risky sexual behaviors by encouraging individuals to consider their future goals. This method aids in better decision-making by reducing the tendency to choose immediate rewards over future benefits. In some studies, up to 90% of participants who used EFT completed their programs, indicating its sustainability. Overall, this trial explores EFT as a way to help people adhere to their HIV prevention medication and make healthier choices.12678
Who Is on the Research Team?
Emeka Okafor, PhD, MPH
Principal Investigator
The University of Texas Health Science Center at San Antonio
Are You a Good Fit for This Trial?
This trial is for sexual minority individuals who are interested in reducing drug use and risky sexual behaviors, while also adhering to HIV prevention medication. Participants should be willing to provide biological samples and use a mobile app as part of the study.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Formative Evaluation
Qualitative interviews with sexual minority individuals to evaluate the Episodic Future Thinking intervention
Treatment
Participants are randomly assigned to either standard care or standard care plus Episodic Future Thinking intervention
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments for PrEP adherence, drug use, and STI testing
What Are the Treatments Tested in This Trial?
Interventions
- EFT
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Texas Health Science Center at San Antonio
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborator